收藏切换
Research progress in the treatment of ankylosing spondylitis
收藏切换
Chunyan LI1, Qian XU2, Guangtao XIA3, *
World Clinical Drug | 2025, 46(6) : 529 - 533
Less
收藏切换
World Clinical Drug | 2025, 46(6): 529-533
• Topic •
Research progress in the treatment of ankylosing spondylitis
Full
Chunyan LI1, Qian XU2, Guangtao XIA3, *
Affiliations
  • 1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China
  • 2.Department of Internal Medicine, Military Retirement Clinic, Jinan Municipal Government Hospital, Jinan 250001, Shandong Province, China
  • 3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
Published: 2025-06-10 doi: 10.13683/j.wph.2025.06.001
Outline
收藏切换

Ankylosing spondylitis(AS) is an autoimmune disease mainly characterized by chronic inflammation of the axial spinal joints, and its onset is significantly correlated with genetic markers such as human leukocyte antigen B27. AS has the characteristics of multi-system involvement and can cause extra-articular manifestations such as gastrointestinal dysfunction, renal damage and skin and mucosal lesions. The clinical treatment drugs for AS mainly include three categories: non-steroidal anti-inflammatory drugs, glucocorticoids and antirheumatic drugs for improving the condition. With the breakthrough of biological targeted therapy, biological agents such AS tumor necrosis factor inhibitors and interleukin-17 inhibitors have become a new paradigm for the treatment of AS. This paper systematically reviewed the latest research on AS biological agents combined with AS physical rehabilitation, exercise therapy and other non-pharmaceutical intervention methods, aiming to provide evidence-based basis for optimizing the comprehensive management plan of AS.

biological agent  /  ankylosing spondylitis  /  tumor necrosis factor-α inhibitor
李春艳, 许芊, 夏光涛. 强直性脊柱炎治疗研究进展. 世界临床药物, 2025 , 46 (6) : 529 -533 . DOI: 10.13683/j.wph.2025.06.001
Chunyan LI, Qian XU, Guangtao XIA. Research progress in the treatment of ankylosing spondylitis[J]. World Clinical Drug, 2025 , 46 (6) : 529 -533 . DOI: 10.13683/j.wph.2025.06.001
Year 2025 volume 46 Issue 6
52
12
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.06.001
  • Receive Date:2025-01-28
  • Online Date:2026-11-09
  • Published:2025-06-10
Article Data
Affiliations
History
  • Received:2025-01-28
Funding
Affiliations
    1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China
    2.Department of Internal Medicine, Military Retirement Clinic, Jinan Municipal Government Hospital, Jinan 250001, Shandong Province, China
    3.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.06.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT